These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3364463)

  • 21. Effects of vasopressin on arterial blood pressure and cardiac output in male and female rats.
    Toba K; Crofton JT; Inoue M; Share L
    Am J Physiol; 1991 Nov; 261(5 Pt 2):R1118-25. PubMed ID: 1951759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of vasopressin to hypertension.
    Share L; Crofton JT
    Hypertension; 1982; 4(5 Pt 2):III85-92. PubMed ID: 7049934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H44-9. PubMed ID: 7058912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressor response to vasopressin and norepinephrine in DOC-salt hypertensive and prehypertensive rats.
    Ouchi Y; Yazaki Y; Tsai RC; Ashida T
    Tohoku J Exp Med; 1988 Feb; 154(2):125-33. PubMed ID: 3381222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorrhage in DOC-salt hypertensive rats: plasma and platelet vasopressin.
    Crofton JT; Share L; Brooks DP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R726-31. PubMed ID: 4073293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vasopressin on cerebral blood flow in normotensive and DOC-salt hypertensive rats.
    Janczewski P; Szczepańska-Sadowska E
    Acta Physiol Pol; 1986; 37(1):47-50. PubMed ID: 3788608
    [No Abstract]   [Full Text] [Related]  

  • 29. Sexual dimorphism in vasopressin and cardiovascular response to hemorrhage in the rat.
    Crofton JT; Share L
    Circ Res; 1990 May; 66(5):1345-53. PubMed ID: 2139822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressor mechanisms of vasopressin in DOC-salt hypertensive rats--interaction with autonomic nervous system.
    Matsuguchi H; Schmid PG
    Jpn Circ J; 1982 May; 46(5):531-3. PubMed ID: 7077815
    [No Abstract]   [Full Text] [Related]  

  • 31. Secretion of pressor amounts of vasopressin in experimentally hypertensive rats.
    Iriuchijima J
    Hiroshima J Med Sci; 1985 Sep; 34(3):267-70. PubMed ID: 4066393
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin.
    Cowley AW; Skelton MM; Velasquez MT
    Hypertension; 1985; 7(3 Pt 2):I151-60. PubMed ID: 3888837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of vasopressin in the control of arterial pressure.
    McNeill JR
    Can J Physiol Pharmacol; 1983 Nov; 61(11):1226-35. PubMed ID: 6362804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of an intracerebroventricularly administered vasopressin V1 antagonist on blood pressure and heart rate in deoxycorticosterone-salt hypertensive rats.
    Toba K; Ouchi Y; Liang J; Akishita M; Orimo H
    J Auton Nerv Syst; 1994 Dec; 50(2):123-9. PubMed ID: 7884152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets.
    Crofton JT; Dustan H; Share L; Brooks DP
    J Endocrinol; 1986 Feb; 108(2):191-9. PubMed ID: 3950526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of vasopressin to the maintenance of blood pressure in deoxycorticosterone-salt induced malignant hypertension in spontaneously hypertensive rats.
    Hiwatari M; Abrahams JM; Saito T; Johnston CI
    Clin Sci (Lond); 1986 Feb; 70(2):191-8. PubMed ID: 3956109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute interaction of vasopressin and neurogenic mechanisms in DOC-salt hypertension.
    Matsuguchi H; Schmid PG
    Am J Physiol; 1982 Jan; 242(1):H37-43. PubMed ID: 7058911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.